A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.
Also called NCT07940803
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT07940803
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07940803. Randomized; triple masking; primary purpose treatment. Start 2026-11-13 (anticipated); primary completion 2028-03-25 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Research Study of a New Medicine NNC0662-3168 for Weight Management and Type 2 Diabetes
- Condition
- Overweight
- Condition
- Obesity
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- NNC0662-3168 (Test product-A)
- Intervention (Drug)
- Placebo matched to NNC0662-3168 (Test product-A)
- Intervention (Drug)
- Active Comparator (Product-B)
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct07940803- Content hash
0232a0611499b20fef9c99b88844a8ea818414df411a686926f8d031488d4544